STOCKHOLM, Sept. 29, 2023 /PRNewswire/ — Annexin Pharmaceuticals today announces important progress in the company’s preclinical cancer research where the drug candidate ANXV has shown promising results as a transporter of chemotherapy drugs to kill cancer cells. Within the framework of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.